Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.155
+0.025 (2.21%)
Apr 29, 2026, 9:30 AM EDT - Market open
Entera Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 7.11 | 8.66 | 11.02 | 12.31 | 24.89 | Upgrade
|
| Cash & Short-Term Investments | 7.11 | 8.66 | 11.02 | 12.31 | 24.89 | Upgrade
|
| Cash Growth | -17.92% | -21.41% | -10.48% | -50.55% | 189.68% | Upgrade
|
| Accounts Receivable | - | 0.13 | - | 0.25 | 0.18 | Upgrade
|
| Other Receivables | 0.22 | - | - | - | - | Upgrade
|
| Receivables | 0.22 | 0.13 | - | 0.25 | 0.18 | Upgrade
|
| Prepaid Expenses | 0.04 | 0.03 | - | - | - | Upgrade
|
| Restricted Cash | 7.78 | - | - | - | - | Upgrade
|
| Other Current Assets | 0.16 | 0.16 | 0.24 | 0.29 | 0.25 | Upgrade
|
| Total Current Assets | 15.3 | 8.97 | 11.26 | 12.85 | 25.33 | Upgrade
|
| Property, Plant & Equipment | 0.6 | 0.33 | 0.49 | 0.23 | 0.4 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 0.01 | 0.04 | 0.22 | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.09 | 0.01 | 0.01 | 0.05 | Upgrade
|
| Total Assets | 15.99 | 9.39 | 11.77 | 13.13 | 25.99 | Upgrade
|
| Accounts Payable | 0.45 | 0.13 | 0.08 | 0.02 | 0.17 | Upgrade
|
| Accrued Expenses | 1.16 | 0.87 | 0.87 | 1.23 | 2.67 | Upgrade
|
| Current Portion of Leases | 0.23 | 0.17 | 0.13 | 0.09 | 0.18 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.13 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.02 | Upgrade
|
| Other Current Liabilities | 0.37 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 2.2 | 1.18 | 1.09 | 1.34 | 3.16 | Upgrade
|
| Long-Term Leases | 0.26 | 0.1 | 0.26 | - | 0.12 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.04 | 0.03 | 0.03 | 0.03 | 0.14 | Upgrade
|
| Other Long-Term Liabilities | 0.39 | - | - | - | - | Upgrade
|
| Total Liabilities | 2.89 | 1.31 | 1.38 | 1.37 | 3.42 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | - | Upgrade
|
| Additional Paid-In Capital | 138.43 | 121.97 | 114.73 | 107.21 | 104.95 | Upgrade
|
| Retained Earnings | -125.37 | -113.93 | -104.39 | -95.5 | -82.43 | Upgrade
|
| Comprehensive Income & Other | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Shareholders' Equity | 13.1 | 8.08 | 10.39 | 11.75 | 22.57 | Upgrade
|
| Total Liabilities & Equity | 15.99 | 9.39 | 11.77 | 13.13 | 25.99 | Upgrade
|
| Total Debt | 0.49 | 0.27 | 0.39 | 0.09 | 0.3 | Upgrade
|
| Net Cash (Debt) | 6.62 | 8.39 | 10.63 | 12.22 | 24.59 | Upgrade
|
| Net Cash Growth | -21.10% | -21.08% | -13.00% | -50.31% | 201.31% | Upgrade
|
| Net Cash Per Share | 0.14 | 0.22 | 0.37 | 0.42 | 0.94 | Upgrade
|
| Filing Date Shares Outstanding | 46.62 | 45.42 | 35.48 | 28.81 | 28.8 | Upgrade
|
| Total Common Shares Outstanding | 46.18 | 38.84 | 35.48 | 28.81 | 28.8 | Upgrade
|
| Working Capital | 13.1 | 7.8 | 10.17 | 11.51 | 22.17 | Upgrade
|
| Book Value Per Share | 0.28 | 0.21 | 0.29 | 0.41 | 0.78 | Upgrade
|
| Tangible Book Value | 13.1 | 8.08 | 10.39 | 11.75 | 22.57 | Upgrade
|
| Tangible Book Value Per Share | 0.28 | 0.21 | 0.29 | 0.41 | 0.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.